Riskpilot← Back to searchSign inGet full accessBMJ A/S
A/SActiveCVR 27465722Drejervænget 8Rental and operating of own or leased real estate · NACE 6820Est. 2003— employees
Revenue 2025
DKK 736K
+8% vs 2024
EBITDA margin
668.2%
+623% vs 2024
Equity ratio
47.7%
Financial strength
Net profit 2025
DKK 4M
+1318% vs 2024
| Revenue | DKK 736K | +8% |
| EBITDA | DKK 4,9M | +623% |
| Net profit | DKK 4M | +1318% |
| Total assets | DKK 12,9M | +180% |
| Equity | DKK 6,1M | +162% |
| Employees | — | — |
Legal name
BMJ A/S
CVR number
27465722
Legal form
Aktieselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
2. december 2003
Share capital
DKK 500.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at drive handel og industri.
Address
Drejervænget 8
Phone
+4529806064
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 11 | 168 | 676 | 191 | 115 | 394 | 701 | 578 | 249 | 529 | 674 | 680 | 736 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -474 | 11 | 168 | 676 | 191 | 115 | 394 | 701 | 578 | 249 | 529 | 674 | 680 | 4.918 |
| Depreciation & amort. | -0 | -77 | -104 | -183 | -219 | -219 | -219 | -219 | -219 | -219 | -219 | -219 | 219 | -0 |
| EBIT | -474 | -65 | 65 | 493 | -28 | -104 | 175 | 482 | 359 | 30 | 310 | 455 | 461 | 4.918 |
| Net financials | -28 | 0 | -16 | -41 | -29 | -30 | -25 | -18 | -14 | -14 | -93 | -60 | -39 | -50 |
| Profit before tax | -502 | -65 | 49 | 452 | -57 | -134 | 149 | 464 | 345 | 16 | 218 | 395 | 423 | 4.867 |
| Tax | -0 | -0 | -0 | -12 | -71 | 77 | 82 | 151 | 124 | 52 | 102 | 135 | 141 | 874 |
| Net profit | -502 | -65 | 49 | 463 | 14 | -212 | 68 | 313 | 220 | -36 | 116 | 260 | 282 | 3.993 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 481 | 303 | 6.067 | 5.876 | 5.394 | 4.918 | 4.950 | 4.500 | 4.304 | 4.297 | 4.372 | 4.207 | 4.597 | 12.875 |
| Equity | -24 | -89 | -41 | 1.106 | 1.120 | 909 | 976 | 1.303 | 1.523 | 1.487 | 1.603 | 2.060 | 2.341 | 6.138 |
| Long-term debt | 0 | 0 | 2.469 | 2.426 | 2.242 | 2.095 | 2.064 | 1.945 | 1.799 | 1.593 | 102 | 135 | 141 | 151 |
| Short-term debt | 505 | 392 | 3.639 | 2.134 | 1.822 | 1.705 | 1.700 | 905 | 785 | 1.021 | 2.470 | 2.013 | 2.115 | 5.667 |
| Total debt | 505 | 392 | 6.108 | 4.559 | 4.064 | 3.800 | 3.764 | 3.001 | 2.584 | 2.613 | 2.572 | 2.148 | 2.256 | 5.818 |
EBITDA margin
668.2%
This company
15.8%
Market median
+4129% vs market
20122025
Equity ratio
47.7%
This company
38.2%
Market median
+25% vs market
20122025
Return on equity
65.1%
This company
18.4%
Market median
+254% vs market
20122025
Net profit margin
542.6%
This company
8.1%
Market median
+6599% vs market
20122025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
MK Management | Management | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Chairman | 2003 | — | — | |
| Chairman | 2004 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2003 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DAN-TOP ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AXELSSON HOLDING ApS
BMJ A/S Board members of BMJ A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Madsen | Chief Executive Officer | 0 companies |
| Morten Kirk Axelsson | Management | 0 companies |
| Tina Louise Skov Panstrup | Board of Directors | 0 companies |
| Annemette Heller | Chairman | 0 companies |
| Mads Jacobsen | Chairman | 0 companies |
| Jan Henrik Søe-Pedersen | Chairman | 0 companies |
| Helle Garde Carlsen | Board of Directors | 0 companies |